Collection Patents [0/39] Periodical Articles [31/31] Siblings Su-Ying Wu [53/74] Others [59/61] Kak-Shan Shia [77/157] Yueh Andrew Yueh [29/34] Chung-Ming Chang [7/9] Jang-Yang Chang [23/24] Chun-Ping Chang [21/38] John Tsu-An Hsu [170/241] Shiow-Ju Lee [76/108] Jinq-Chyi Lee [24/28] Shu-Yu Lin [21/31] Ming-Shiu Hung [33/44] Shiow-Lin Pan(2009-2013) [16/17] Wen-Chieh Wang [13/15] Hung-Jung Wang [7/7] Chuan Shih(2014-2017) [36/105] Chun-Wei Tung [25/25] Ya-Hui Chi [22/28] Shau-Hua Ueng [23/43] Hong Zhuang [1/1] Shiu-Hwa Yeh [25/45] Teng-Kuang Yeh [137/160] Weir-Torn Jiaang [43/99] Hsing-Pang Hsieh [180/261] Yu-Sheng Chao(2002-2013) [120/279] Ching-Chuan Kuo [53/59] Lun Kelvin Tsou [31/71] Xin Chen(2002-2015) [53/68] Chiung-Tong Chen [184/268] Wan-Ching Yen [6/8] Ming-Chu Hsu(1997-2001) [3/10] Shu-Jung Chen(1998-2001) [3/11] Hua-Chien Chen(1997-2001) [9/9] Community Statistics Item counts issued in 3 years:6(8.57%) Items With Fulltext:31(44.29%) Download counts of the item Download times greater than 0:31(100.00%) Download times greater than 100:31(100.00%) Total Bitstream Download Counts:26958(0.46%) Last Update: 2025-05-04 17:54 Top Upload Loading... Top Download Loading... Recent Submissions 增加細胞吞噬作用之方法 Proline derivatives for use to trea... Proline derivatives Proline derivatives 프롤린 유도체 脯氨酸衍生物 Benzimidazole compounds and use the... 脯氨酸衍生物 Benzimidazole compounds and use the... 苯并咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-50 of 70. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2024-01-14	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	SG11202101274X/2024-01-14
2023-06-01	增加細胞吞噬作用之方法	TWI804339/2023-06-01
2023-03-03	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	IN424040/2023-03-03
2023-01-27	苯並咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途	HK40053325/2023-01-27
2023-01-26	苯并咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途	J/006659/2023-01-26
2023-01-24	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	CA3109623/2023-01-24
2022-08-23	苯并咪唑化合物及其在制备治疗阿兹海默症或亨丁顿氏症的药物中的用途	CN113613652/2022-08-23
2022-08	Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3beta and phosphorylated AKT expression levels	Journal of Microbiology, Immunology, and Infection. 2022 Aug;55(4):598-610.
2022-05-31	벤즈이미다졸 화합물 및 알츠하이머 질환 또는 헌팅톤병을 치료하기 위한 그의 용도	KR 10-2405760/2022-05-31
2022-03-14	ベンズイミダゾール化合物,及びアルツハイマー病又はハンチントン病の治療のためのその使用	JP7035275/2022-03-14
2021-11-11	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	AU2019333295/2021-11-11
2021-01-01	苯并咪唑化合物及其用於治療阿茲海默症或亨丁頓氏症之用途	TWI715156/2021-01-01
2020-12	Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors	Emerging Microbes and Infections. 2020 Dec;9(1):1194-1205.
2020-03-10	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	US10584120/2020-03-10
2019-12	A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses	Antiviral Research. 2019 Dec;172:Article number 104636.
2019-04-01	A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus	European Journal of Medicinal Chemistry. 2019 Apr 1;167:245-268.
2019-03-20	Proline derivatives	EP2507232/2019-03-20
2018-09	Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication	Journal of Virological Methods. 2018 Sep;259:10-17.
2017-12	Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels	Journal of Cellular Physiology. 2017 Dec;232(12):3409-3421.
2017-10-24	Proline derivatives for use to treat hepatitis c infection	CA2781140/2017-10-24
2017-08-10	프롤린 유도체	KR10-1768946/2017-08-10
2017-06	Mutagenesis of dengue virus protein NS2A revealed a novel domain responsible for virus-induced cytopathic effect and interactions between NS2A and NS2B transmembrane segments	Journal of Virology. 2017 Jun;91(12):Article number e01836-16.
2017-01	A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide	Journal of Medicinal Chemistry. 2017 Jan;60(1):228-247.
2016-07-21	Proline derivatives	AU2010325980/2016-07-21
2016-07	In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71	Journal of Antimicrobial Chemotherapy. 2016 Jul;71(7):1922-1932.
2016-06-17	脯氨酸衍生物	HK1171439/2016-06-17
2016-02-04	脯氨酸衍生物	J/001913/2016-02-04
2015-07-29	脯氨酸衍生物	CN102482269/2015-07-29
2015-05-29	Proline derivatives	JP5753185/2015-05-29
2014-09-01	治療阿茲海默症或帕金森氏症之醫藥組成物	TWI450716/2014-09-01
2014-03-11	脯胺酸衍生物	TWI429645/2014-03-11
2014-01	A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease	Antimicrobial Agents and Chemotherapy. 2014 Jan;58(1):110-119.
2013-04-09	Proline derivatives	US8415482/2013-04-09
2013-02	Resistance studies of a di-thiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems	Antimicrobial Agents and Chemotherapy. 2013 Feb; 57(2):723-733.
2012-06-12	Treatment of neurodegenerative disorders with thiourea compounds	US8198284/2012-06-12
2012-04-11	咪唑啉酮及咪唑啉硫酮衍生物	TWI361808/2012-04-11
2012-03-01	C型肝炎病毒抑制劑	TWI359137/2012-03-01
2012-01	Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor	Antimicrobial Agents and Chemotherapy. 2012 Jan;56(1):44-53.
2011-07-26	Hepatitis C virus inhibitors	US7985763/2011-07-26
2011-05-10	Imidazolidinone and imidazolidinethione derivatives	US7939523/2011-05-10
2011-04	Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer	Investigational New Drugs. 2011 Apr;29(2):195-206.
2011-04	Isatin-beta-thiosemicarbazones as potent herpes simplex virus inhibitors	Bioorganic and Medicinal Chemistry Letters. 2011 Apr;21(7):1948-1952.
2011-03-01	Thiourea derivatives	US7897764/2011-03-01
2011-01	Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay	Antimicrobial Agents and Chemotherapy. 2011 Jan;55(1):229-238.
2011-01	BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities	Cancer Science. 2011 Jan;102(1):182-191.
2010-10	Modulation of microglial immune responses by a novel thiourea derivative	Chemico-Biological Interactions. 2010 Oct;188(1):228-236.
2010-09-01	Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors	Bioorganic and Medicinal Chemistry. 2010 Sep ;18(17):6414-6421.
2010-08-21	硫尿化合物及抑制C型肝炎病毒感染之方法	TWI329102/2010-08-21
2010-05-11	咪唑啉酮化合物	TWI324594/2010-05-11
2009-11-01	Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors	Bioorganic and Medicinal Chemistry Letters. 2009 Nov 1;19(21):6063-6068.

Showing items 1-50 of 70. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page